መነሻ › ዋና የድንጋጠ መዳከም ችግር › ኮነቲከት
በኮነቲከት ለዋና የድንጋጠ መዳከም ችግር የሚደረጉ ክሊኒካዊ ጥናቶች
ለዋና የድንጋጠ መዳከም ችግር የሚደረጉ 16 ጥናቶች በኮነቲከት ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በኮነቲከት ውስጥ ያሉ ከተሞች
Official study text (English)
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- UConn Health Center, Farmington
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Connecticut Health Center, Farmington
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Cromwell
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Institute of Living, Hartford
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07076407A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Yale University School of Medicine, New Haven
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Ct Clinical Research Associates, Cromwell
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- University of Connecticut School of Medicine Psychiatry Department, Farmington
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 64 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06547489A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, New Haven
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁላይ 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cromwell
- Neurocrine Clinical Site, Farmington
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁላይ 2026 · NCT06966401The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- VA Connecticut Healthcare System, West Haven
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ21 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT05786066Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
- Yale University, New Haven
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 60 · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT05915013Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Hartford Hospital, Hartford
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 40 · ሁሉም ጾታዎች · የተሻሻለው በ10 ማርች 2026 · NCT06740383Imaging Depression in Parkinson's Disease
- Yale University, New Haven
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ40 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ማርች 2026 · NCT06402955Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #122, Cromwell
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ20 ጃንዩ 2026 · NCT06633016Study of ALTO-300 in MDD
- Site 214, Norwalk
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁላይ 2025 · NCT05922878ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።